ScoutQuest29 Sep 2026
Allcargo Logistics532749CEO role change

MD & CEO Ketan Kulkarni to move to Group role; Vijay Nehra named MD Designate

Leadership change announced.

Outgoing MD & CEO Role Change
Ketan Kulkarni resigns as MD & CEO to become Chief Growth Officer, Allcargo Group, effective January 1, 2027
New MD & CEO Appointment
Vijay Nehra appointed Chief Transformation Officer & MD Designate effective October 1, 2026, becomes MD & CEO January 1, 2027 subject to…
Reporting Structure
Both Ketan Kulkarni and Vijay Nehra will report to Punit Misra, Chief Business Officer, Allcargo Group

What was announced

Allcargo Logistics has disclosed a leadership transition at the top of the company.

Transition arrangement

Nehra will work closely with the existing leadership during the transition period of roughly three months before stepping into the MD & CEO role. Kulkarni has said he will work with Nehra over the coming months to ensure a smooth handover.

In his Group role, Kulkarni will spearhead sales and marketing initiatives, with a focus on identifying new growth opportunities across emerging industries. Both Nehra and Kulkarni will report to Punit Misra, Chief Business Officer, Allcargo Group.

Context given by the company

The company describes this as part of the broader strategic restructuring of the Allcargo Group following the demerger, with businesses moving towards more focused leadership and governance structures. The earlier appointment of Dinesh Lal as Chairman was cited as a step in the same direction.

About the incoming MD Designate

Vijay Nehra has held senior leadership roles across financial services, pharmaceuticals, FMCG, e-commerce and technology-led businesses. He was a supply chain professional at Hindustan Unilever, later Head of Finance at Indiabulls Real Estate and Indiabulls Housing Finance, then CEO of Indiabulls Asset Reconstruction Company, and most recently CEO of Ozone Pharma. A Master Mariner, he holds a post graduate programme in management from ISB, Hyderabad and a Bachelor of Nautical Sciences from T. S. Chanakya, University of Mumbai.

What it means for investors

This is a management change rather than a business or financial event. A change of chief executive is often watched closely for continuity of strategy; here the company frames it as a planned realignment, with the outgoing MD & CEO remaining within the Group and a defined overlap period before the handover. The new appointment as MD & CEO is subject to shareholder approval.

Source: BSE · 29 Sep 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.